Woodline Partners’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-569,212
| Closed | -$860K | – | 687 |
|
|
2023
Q1 | $860K | Hold |
569,212
| – | – | 0.01% | 484 |
|
|
2022
Q4 | $1.42M | Sell |
569,212
-228,694
| -29% | -$572K | 0.02% | 516 |
|
|
2022
Q3 | $3.37M | Sell |
797,906
-20,256
| -2% | -$85.5K | 0.05% | 366 |
|
|
2022
Q2 | $2.28M | Buy |
818,162
+249,007
| +44% | +$695K | 0.04% | 406 |
|
|
2022
Q1 | $3.26M | Buy |
569,155
+11,356
| +2% | +$65K | 0.05% | 300 |
|
|
2021
Q4 | $5.09M | Buy |
+557,799
| New | +$5.09M | 0.07% | 278 |
|